Occidental Asset Management, LLC

Position in GILD — Gilead Sciences, Inc.

CIK 1770994 Burlingame, CA

Position in GILD

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$4,384,124

-$267,489 QoQ

Shares Held

34,701

+4.0% QoQ

Ownership

0.003%

of shares outstanding

% of Portfolio

0.72%

of 13F equity value

Holder Rank

#612

of 2,266 holders

Holding Since

Mar 2020

14 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Occidental Asset Management, LLC holds $27,487,329 across 9 Drug Manufacturers - General names. GILD ranks #3 (15.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	MRK	Merck & Co., Inc.	56,777	$7,295,844
2	AMGN	Amgen Inc	17,469	$6,325,874
3	GILD	Gilead Sciences, Inc. This page	34,701	$4,384,124
4	ABBV	AbbVie Inc.	10,577	$2,661,596
5	LLY	ELI LILLY & Co	2,219	$2,661,535
6	JNJ	Johnson & Johnson	7,491	$1,902,489
7	NVS	Novartis AG	10,018	$1,570,020
8	BMY	Bristol Myers Squibb Co	7,807	$449,839

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$4,384,124	34,701	+4.0%	Shares	Sole	2026-08-07
2026-03-31	$4,651,613	33,376	-20.1%	Shares	Sole	2026-04-16
2025-12-31	$5,127,586	41,776	+1.6%	Shares	Sole	2026-01-08
2025-09-30	$4,564,098	41,118	+1.1%	Shares	Sole	2025-10-29
2025-06-30	$4,509,082	40,670	+1.4%	Shares	Sole	2025-07-14
2025-03-31	$4,495,333	40,119	+3.9%	Shares	Sole	2025-05-15
2024-12-31	$3,566,959	38,616	+11.5%	Shares	Sole	2025-01-15
2024-09-30	$2,903,882	34,636	+9.3%	Shares	Sole	2024-10-15
2024-06-30	$2,173,290	31,676	+10.9%	Shares	Sole	2024-07-15
2024-03-31	$2,093,118	28,575	+57.9%	Shares	Sole	2024-04-16
2020-12-31	$1,054,214	18,095	+9.0%	Shares	Sole	2021-01-28
2020-09-30	$1,049,459	16,608	+2.2%	Shares	Sole	2020-11-10
2020-06-30	$1,250,582	16,254	+3.2%	Shares	Sole	2020-07-17
2020-03-31	$1,177,694	15,753	—	Shares	Sole	2020-04-23
No filing history on record for this holder in this stock.